Related references
Note: Only part of the references are listed.Intrafamilial phenotypic variability in four families with Anderson-Fabry disease
M. Rigoldi et al.
CLINICAL GENETICS (2014)
Anderson-Fabry Disease in Children
Simona Sestito et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Prevalence of symptoms in female Fabry disease patients: a case-control survey
Machtelt G. Bouwman et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature
Antonio Pisani et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Update on role of agalsidase alfa in management of Fabry disease
Uma Ramaswami
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
Fabry disease: a review of current management strategies
A. Mehta et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Fabry disease in children and the effects of enzyme replacement treatment
Guillem Pintos-Morell et al.
EUROPEAN JOURNAL OF PEDIATRICS (2009)
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
Raphael Schiffmann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Enzyme replacement therapy with agalsidase alfa in a cohort of Italian patients with Anderson-Fabry disease: testing the effects with the Mainz Severity Score Index
R. Parini et al.
CLINICAL GENETICS (2008)
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
William R. Wilcox et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Gastrointestinal symptoms in 342 patients with Fabry disease: Prevalence and response to enzyme replacement therapy
Bjoern Hoffmann et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Functional defecation disorders in children: PACCT criteria versus Rome II criteria
Gabrielln Boccia et al.
JOURNAL OF PEDIATRICS (2007)
Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy - A retrospective analysis from the Fabry outcome survey
Bjoern Hoffmann et al.
CLINICAL JOURNAL OF PAIN (2007)
Sustained, long-term renal stabilization after 54 months of agalsidase β therapy in patients with Fabry disease
Dominique P. Germain et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Manifestations of Fabry disease in placental tissue
AC Vedder et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms
A Caplan et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Gastrointestinal manifestations of Fabry disease: Clinical response to enzyme replacement therapy
M Banikazemi et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Irritable bowel syndrome: Epidemiology, natural history, health care seeking and emerging risk factors
F Cremonini et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2005)
Development and preliminary validation of the questionnaire on pediatric gastrointestinal symptoms to assess functional gastrointestinal disorders in children and adolescents
A Caplan et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
A Mehta et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Recurrent abdominal pain: Symptom subtypes based on the Rome II criteria for pediatric functional gastrointestinal disorders
LS Walker et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Effect of enzyme-replacement therapy on gastrointestinal symptoms in Fabry disease
B Hoffmann et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Relief of gastrointestinal symptoms under enzyme replacement therafpy in patients with Fabry disease
F Dehout et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents
M Ries et al.
EUROPEAN JOURNAL OF PEDIATRICS (2003)
Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention
AH Miners et al.
QUALITY OF LIFE RESEARCH (2002)
Anderson-Fabry disease:: Clinical manifestations of disease in female heterozygotes
C Whybra et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Natural history of Fabry disease in affected males and obligate carrier females
KD MacDermot et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Share Paper
